Remedent Sets Fiscal Fourth Quarter and Year End 2009 Conference Call for Wednesday, July 1 at 11:00 a.m. ET
24 June 2009 - 5:25AM
Marketwired
Remedent, Inc. (OTCBB: REMI), an international company specializing
in the research, development, and manufacturing of oral care and
cosmetic dentistry products, will hold a conference call on
Wednesday, July 1, 2009 at 11:00 a.m. Eastern time to discuss
results for its fiscal fourth quarter and year ended March 31,
2009.
Financial results will be issued in a press release prior to the
call. Remedent Chairman Guy De Vreese and CFO Stephen Ross will
host the presentation, followed by a question and answer
period.
Date: Wednesday, July 1, 2009
Time: 11:00 a.m. Eastern time (8:00 a.m. Pacific time)
Dial-In Number: 1-800-894-5910
International: 1-785-424-1052
Conference ID#: 7REMEDENT
A simultaneous webcast and replay of the call will be accessible
via this link: http://viavid.net/dce.aspx?sid=0000666B.
Please call the conference telephone number 5-10 minutes prior
to the start time. An operator will register your name and
organization and ask you to wait until the call begins. If you have
any difficulty connecting with the conference call, please contact
the Liolios Group at 1-949-574-3860.
A telephone replay of the call will be available from 2:00 p.m.
Eastern time on the same day until August 1, 2009.
Toll-free replay number: 1-800-695-0395
International replay number: 1-402-220-1388
(No passcode required)
About Remedent
Remedent, Inc. specializes in the research, development,
manufacturing and marketing of oral care and cosmetic dentistry
products. The company serves professional dental industry with
breakthrough technology for dental veneers, bridges and crowns
which are recognized worldwide for their technological superiority
and ease-of-application. These products are supported by a line of
professional veneer whitening and teeth sensitivity solutions.
Headquartered in Belgium, Remedent distributes its products to more
than 35 countries worldwide. For more information, go to
www.remedent.com.
Contact: Company Contacts: Stephen Ross CFO Remedent, Inc. Tel
310-922-5685 Email Contact Investor Relations: Ron Both Managing
Director Liolios Group, Inc. Tel (949) 574-3860 Email Contact
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024